Limits...
Focal therapy for prostate cancer: The current status.

Marshall S, Taneja S - Prostate Int (2015)

Bottom Line: Minimally invasive therapies are increasingly being investigated in localized prostate cancer.Focal therapy offers a promising outlook for prostate cancer treatment, with the goal of effectively achieving cancer control while minimizing morbidity.Long term studies are needed.

View Article: PubMed Central - PubMed

Affiliation: NYU Langone Medical Center, New York, NY, USA.

ABSTRACT

Purpose: In an era of increasing prostate cancer incidence and earlier detection, the assessment of clinical significance of prostate cancer is critical. Minimally invasive therapies are increasingly being investigated in localized prostate cancer.

Methods and results: In this review, we discuss the current status of magnetic resonance imaging targeted fusion prostate biopsy and focal therapy for prostate cancer, its rationale, and techniques.

Conclusion: Focal therapy offers a promising outlook for prostate cancer treatment, with the goal of effectively achieving cancer control while minimizing morbidity. Long term studies are needed.

No MeSH data available.


Related in: MedlinePlus

Hemi-cryoablation 3T magnetic resonance imaging. T2-weighted image showing atrophic right lobe after hemi-cryoablation. Dynamic contrast enhancement image (right) showing nonenhancing cavity in lobe.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4494637&req=5

fig1: Hemi-cryoablation 3T magnetic resonance imaging. T2-weighted image showing atrophic right lobe after hemi-cryoablation. Dynamic contrast enhancement image (right) showing nonenhancing cavity in lobe.

Mentions: Several other clinical studies have investigated the use of focal cryotherapy since Onik's initial study.39–41 While a majority of trials utilized a hemiablative approach, optimal cryoprobe placement has yet to be determined (Fig. 1). Computer-based technologists have strived to develop and improve cryoprobe placement to maximize destruction of targeted tissue while sparing adjacent noncancerous tissue42 (Figs. 2 and 3).


Focal therapy for prostate cancer: The current status.

Marshall S, Taneja S - Prostate Int (2015)

Hemi-cryoablation 3T magnetic resonance imaging. T2-weighted image showing atrophic right lobe after hemi-cryoablation. Dynamic contrast enhancement image (right) showing nonenhancing cavity in lobe.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4494637&req=5

fig1: Hemi-cryoablation 3T magnetic resonance imaging. T2-weighted image showing atrophic right lobe after hemi-cryoablation. Dynamic contrast enhancement image (right) showing nonenhancing cavity in lobe.
Mentions: Several other clinical studies have investigated the use of focal cryotherapy since Onik's initial study.39–41 While a majority of trials utilized a hemiablative approach, optimal cryoprobe placement has yet to be determined (Fig. 1). Computer-based technologists have strived to develop and improve cryoprobe placement to maximize destruction of targeted tissue while sparing adjacent noncancerous tissue42 (Figs. 2 and 3).

Bottom Line: Minimally invasive therapies are increasingly being investigated in localized prostate cancer.Focal therapy offers a promising outlook for prostate cancer treatment, with the goal of effectively achieving cancer control while minimizing morbidity.Long term studies are needed.

View Article: PubMed Central - PubMed

Affiliation: NYU Langone Medical Center, New York, NY, USA.

ABSTRACT

Purpose: In an era of increasing prostate cancer incidence and earlier detection, the assessment of clinical significance of prostate cancer is critical. Minimally invasive therapies are increasingly being investigated in localized prostate cancer.

Methods and results: In this review, we discuss the current status of magnetic resonance imaging targeted fusion prostate biopsy and focal therapy for prostate cancer, its rationale, and techniques.

Conclusion: Focal therapy offers a promising outlook for prostate cancer treatment, with the goal of effectively achieving cancer control while minimizing morbidity. Long term studies are needed.

No MeSH data available.


Related in: MedlinePlus